Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference
HAMPTON, N.J., Nov. 27, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28th at 5:05 pm ET. A webcast of the presentation will be available on the “Events & Presentations” page of the “Investors & Media” section of the Celldex website. A replay will be available for 90 days following the event.
Related news for (CLDX)
- Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
- Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025
- Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- celldex therapeutics presents landmark 52 week results from barzolvolimab phase 2 study in chronic spontaneous urticaria at eadv 2024
- Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
